Lv2
120 积分 2024-09-22 加入
Evaluation and management of body composition changes in cancer patients
5小时前
已完结
Gut microbiome-derived butyrate inhibits the immunosuppressive factors PD-L1 and IL-10 in tumor-associated macrophages in gastric cancer
5个月前
已完结
Fecal Microbiota Transplantation as a Cancer Therapeutic
5个月前
已完结
Cutaneous adverse events caused by immune checkpoint inhibitors
5个月前
已完结
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
5个月前
已完结
Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor
5个月前
已完结
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
5个月前
已完结
A viable remedy for overcoming resistance to anti-PD-1 immunotherapy: Fecal microbiota transplantation
5个月前
已完结
Modulating the gut microbiome in non-small cell lung cancer: Challenges and opportunities
5个月前
已完结
The implication of microbiome in lungs cancer: mechanisms and strategies of cancer growth, diagnosis and therapy
5个月前
已完结
皖公网安备34019202002308
